Abstract:BACKGROUND:The identification of cancer-associated long non-coding RNAs and the investigation of their molecular and biological functions are important for understanding the molecular biology and progression of cancer. HOTAIR (HOX transcript antisense intergenic RNA) has been implicated in several cancers; however, its role in non-small cell lung cancer (NSCLC) is unknown. The aim of the present study was to examine the expression pattern of HOTAIR in NSCLC and to evaluate its biological role and clinical significance in tumor progression.METHODS:Expression of HOTAIR was analyzed in 42 NSCLC tissues and four NSCLC cell lines by quantitative reverse-transcription polymerase chain reaction (qRT-PCR). Over-expression and RNA interference (RNAi) approaches were used to investigate the biological functions of HOTAIR. The effect of HOTAIR on proliferation was evaluated by MTT and colony formation assays, and cell migration and invasion were evaluated by transwell assays. Tail vein injection of cells was used to study metastasis in nude mice. Protein levels of HOTAIR targets were determined by western blot analysis. Differences between groups were tested for significance using Student's t-test (two-tailed).RESULTS:HOTAIR was highly expressed both in NSCLC samples and cell lines compared with corresponding normal counterparts. HOTAIR upregulation was correlated with NSCLC advanced pathological stage and lymph-node metastasis. Moreover, patients with high levels of HOTAIR expression had a relatively poor prognosis. Inhibition of HOTAIR by RNAi decreased the migration and invasion of NSCLC cells in vitro and impeded cell metastasis in vivo. HOXA5 levels were affected by HOTAIR knockdown or over-expression in vitro.CONCLUSIONS:Our findings indicate that HOTAIR is significantly up-regulated in NSCLC tissues, and regulates NSCLC cell invasion and metastasis, partially via the down-regulation of HOXA5. Thus, HOTAIR may represent a new marker of poor prognosis and is a potential therapeutic target for NSCLC intervention.

The Role and Mechanism of Long Non-Coding RNA HOTAIR in the Oncogenesis, Diagnosis, and Treatment of Head and Neck Squamous Cell Carcinoma

Long Noncoding RNA HOTAIR Involvement in Cancer.

The Long Non-Coding RNA HOTAIR Indicates a Poor Prognosis and Promotes Metastasis in Non-Small Cell Lung Cancer.

Current Knowledge of Long Non-Coding RNA HOTAIR in Breast Cancer Progression and Its Application

Research Progress of Long Non-Coding RNA HOTAIR in the Human Cancers

HOTAIR: An Oncogenic Long Non-Coding RNA in Human Cancer

Long non-coding RNAs in head and neck squamous cell carcinoma: Diagnostic biomarkers, targeted therapies, and prognostic roles

Large Intervening Non-Coding RNA HOTAIR Is an Indicator of Poor Prognosis and a Therapeutic Target in Human Cancers

Role of the long non-coding RNA HOTAIR in hepatocellular carcinoma

Emerging Roles of HOTAIR in Human Cancer

Long Non-Coding Rna Hotair Promotes Tumor Cell Invasion And Metastasis By Recruiting Ezh2 And Repressing E-Cadherin In Oral Squamous Cell Carcinoma

Long Noncoding RNA (lncrna) HOTAIR: Pathogenic Roles and Therapeutic Opportunities in Gastric Cancer

Progress of Long Noncoding Rna Hotair in Human Cancer

A Feed-Forward Regulatory Loop Between HuR and the Long Noncoding RNA HOTAIR Promotes Head and Neck Squamous Cell Carcinoma Progression and Metastasis

LncRNA HOTAIR promotes the invasion and metastasis of oral squamous cell carcinoma through metastasis-associated gene 2.

Long Non-Coding RNA HOTAIR is a Marker for Hepatocellular Carcinoma Progression and Tumor Recurrence.

Long non-coding RNA HOTAIR is an independent prognostic marker for nasopharyngeal carcinoma progression and survival.

The Role of Long Non-Coding RNAs in the Pathogenesis of Head and Neck Squamous Cell Carcinoma

High Expression of Long Non‑coding HOTAIR Correlated with Hepatocarcinogenesis and Metastasis

Long non-coding RNA HOTAIR: from pan-cancer analysis to colorectal cancer-related uridine metabolism

Serum HOTAIR As a Novel Diagnostic Biomarker for Esophageal Squamous Cell Carcinoma